Celgene's Abraxane increases survival in pancreatic cancer
(Reuters) - Celgene Corp said its Abraxane drug helped patients with advanced pancreatic cancer live an average of two months longer than chemotherapy...
Source: http://goo.gl/mag/EjNqrjJ
Celgene's Abraxane increases survival in pancreatic cancer
(Reuters) - Celgene Corp said its Abraxane drug helped patients with advanced pancreatic cancer live an average of two months longer than chemotherapy...
Source: http://goo.gl/mag/EjNqrjJ
No comments:
Post a Comment